产品中心 Products
最新新闻 / News More
1
2018 - 06 - 08
2018年6月6日讯 /生物谷BIOON /——PERIOD 2 (PER2)蛋白的多点磷酸化是决定哺乳动物生物钟周期的关键步骤。过去的研究认为PER2被酪蛋白激酶1(CK1)磷酸化的过程需要一种未被发现的蛋白激酶来启动,而CK1是一种从藻类到人类都高度保守的生物钟必需蛋白。这些磷酸化过程可以稳定PER2,延缓其降解以延长生物钟周期。图片来源:CCO public domain为了找到这个必需的蛋白质,一个由杜克-新加坡国立大学医学院研究人员领导的国际团队对小鼠PER2启动磷酸化的过程进行了综合的生物化学和生物物理学分析,结果惊讶地发现CK1δ/ε就是他们寻找的启动激酶。此外,他们还发现CK1ε和一个最近发现的CK1δ2剪接变体可以比CK1δ1更有效地启动磷酸化。尽管过去研究显示CK1对PER2的磷酸化对细胞环境很不敏感,但是研究人员通过使用生物节律磷酸化开关数学模型发现CK1羧基端尾部使得生物钟周期对细胞信号敏感。这些研究表明CK1羧基端是生物节律的一个重要的调节因子。(生物谷Bioon.com)参考资料:Rajesh Narasimamurthy et al, CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch, Proceedings of the National Academy of Sci...
2
2019 - 03 - 22
给你一个冰淇淋和一块蛋糕,你先吃哪个?一块面包和一个牛油果呢?两个一块吃吗?1941 年微生物学家 Jacques Monod 给细菌提出了同样的问题。他给大肠杆菌同时提供两种食物(碳源),结果看到了两类不同的现象:对某一些食物组合(比麦芽糖和苹果酸),细菌两种同时吃,而对另一些组合(比如葡萄糖和乳糖),细菌要先吃完一种(葡萄糖),然后再会去吃另一种(乳糖)。随后 Monod 和 François Jacob 一道,找出了细菌在有葡萄糖和乳糖的情况下只吃葡萄糖的分子机制—乳糖操纵子:在这两种糖都存在的时候,细胞不会去表达运输和消化乳糖的相关基因,并获得了 1965 年的诺贝尔生理学奖。可是为什么细菌要挑食呢?为什么对于有些食物的组合它们又不挑呢?北京大学汤超教授团队发现细菌的这一套进食策略能够使它们最优化的生长。如果哪个菌种想任性一把,同时吃葡萄糖和乳糖,或者对麦芽糖和苹果酸挑食,那么它们的代价就是生长速率的降低,进而面临被淘汰的危险。结合代谢网络的拓扑特征和细胞内蛋白资源的优化分配,研究团队的理论模型定量的解释了细菌面对多种碳源的进食策略。在两类碳源同时被细菌消耗的情况下,模型预测并用实验验证了细菌内不同氨基酸上的碳原子来自两种碳源的比例。这个例子进一步说明了在看似复杂的生命现象中,存在简洁的原理与定量的规律。相关文章发表在《自然 - 通讯》杂志上。北京大学定量生物学中...
3
2019 - 07 - 26
科技日报北京 7 月 30 日电 (记者付丽丽)“建立严格的法律责任制度,对违反《疫苗管理法》规定构成犯罪的,依法从重追究刑事责任,货款不足 50 万元的按 50 万元计算。”30 日,在国家药监局主办的 “《疫苗管理法》颁布法规解读宣贯研讨会上”,该局政策法规司副司长吴丽雅说。《疫苗管理法》是全球首部综合性疫苗管理法律。具体来讲,吴丽雅介绍,生产、销售的疫苗属于假药的,没收违法所得和违法生产、销售的疫苗以及专门用于违法生产疫苗的原料、辅料、包装材料、设备等物品,责令停产停业整顿,吊销药品注册证书,直至吊销药品生产许可证等,并处违法生产、销售疫苗货值金额 15 倍以上 50 倍以下的罚款。生产、销售的疫苗属于劣药的,处违法生产、销售疫苗货款金额 10 倍以上 30 倍以下罚款。吴丽雅为读者算了一笔账。生产、销售的疫苗属于假药的,最低罚款:50 万元 ×(15 倍至 50 倍)=750 万元至 2500 万元;生产、销售的疫苗属于劣药的,最低罚款: 50 万元 ×(10 倍至 30 倍)=500 万元至 1500 万元。疫苗是特殊的药品,事关公共安全。吴丽雅表示,长春长生问题疫苗事件暴露出我国在疫苗监管方面存在主体责任不落实、质量安全管理不到位、职业化专业化监管力量薄弱等问题。鉴于此,《疫苗管理法》明确提出国家对疫苗实行最严格的管理制度,对疫苗的研制、生产、流通、...
联系我们
北京照生行仪器设备有限公司
销售热线:010-62929079
公司总机:010-62929079
图文传真:010-62929277
总部地址:北京市海淀区西二旗西路热力公司院内泰禾文化园二层
产品名称:

Dynabeads™ CD45

上市日期: 2019-04-17
产品类别: INVITROGEN

Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


  • 产品描述
  • 产品功能
  • 产品参数

Description

Dynabeads® CD45 are superparamagnetic beads covalently coupled to anti-human CD45 antibody that enable isolation or depletion of CD45+ leucocytes directly from whole blood, buffy coat, or MNC suspensions. Dynabeads® CD45 can also be used to enrich epithelial tumor cells. The CD45 antigen is weakly expressed on myeloid cells. To efficiently deplete or isolate all leucocytes including myeloid cells, use Dynabeads® CD15 (Cat. No. 11137D) in combination with Dynabeads® CD45. Advantages of Dynabeads® CD45:

• Efficient depletion of human leucocytes
• Isolation of leucocytes directly from whole blood for molecular applications
• Enrichment of circulating epithelial tumor cells

About Dynabeads® CD45
Dynabeads® CD45 are uniform, superparamagnetic beads (4.5 µm diameter) coated with a primary monoclonal mouse IgG2a antibody specific for a CD45 membrane antigen common to all known isoforms of CD45. CD45 is expressed on all human leucocytes. Because of the bead size, Dynabeads® CD45 can easily and efficiently isolate or deplete cells from viscous samples such as whole blood and bone marrow in about 30 minutes. Dynabeads® CD45 is often used for enrichment of circulating non-hematopoietic tumor cells, by depletion of all CD45+ leucecytes from a MNC sample. Positively isolated cells can be used for downstream molecular studies; for example, those in which cells are to be lysed while still attached to beads, and nucleic acids or proteins further purified. Note that intact cells will not be released from these beads, and we do not recommend to analyze the bead-bound cells with a flow cytometer.

Magnetic bead–based separation offers easy handling
Dynabeads® CD45 is added to the sample under continuous mixing to optimize the binding of the Dynabeads® to the target cells. By placing the sample on a magnet it separates the bead-bound target cells from the rest of the sample in just 1–2 minutes. For depletion, remove the supernatant to a new tube for further studies and discard the bead-bound cells. For positive isolation for molecular studies, remove the supernatant and wash the bead-bound cells 2–3 times in buffer to get optimal purity. The cells can be lysed while still attached to the beads and the supernatant transferred to a new tube for downstream molecular analysis. Starting samples can be whole blood, buffy coat, bone marrow, PBMC, or tissue digests.


Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


推荐新闻
地址:中国·北京·海淀区-西二旗西路热力公司院内泰禾文化园二层
电话:010-62929079
Copyright@ 2015-2016 北京照生行仪器设备有限公司
传真:+86 0755-2788 8009
邮编:330520